Gilead Sciences, Inc. (GILD) Q4 2023 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Gilead Sciences, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.009 -- 00:00:04.853 Victoria, Good afternoon, thank you for attending the fourth quarter and full year 2023 00:00:04.853 -- 00:00:09.717 Gilead sciences earning conference call my name is Victoria and i'll be your moderator 00:00:09.717 -- 00:00:13.940 today. Victoria, All lines will be muted during the presentation portion of the call 00:00:13.940 -- 00:00:18.424 with opportunity for questions and answers at the end, I would now like to pass the conference 00:00:18.424 -- 00:00:21.666 over to your host Jackie Ross Thank you, you may proceed Jackie. 00:00:21.666 -- 00:00:25.407 Jackie Ross Thank you operator and good afternoon everyone. 00:00:25.407 -- 00:00:29.169 Just after market closed today, we issued a press release with earnings results for the 00:00:29.169 -- 00:00:34.172 fourth quarter and full year of 2023. The press release, slides, and 00:00:34.172 -- 00:00:39.276 supplementary data are available on the investor section of our website at gilead.com. 00:00:39.276 -- 00:00:43.658 The speakers on today's call will be our Chairman and Chief Executive Officer, Daniel 00:00:43.658 -- 00:00:49.042 O'Day, our Chief Commercial Officer, Joanna Mercier, our Chief Medical Officer, 00:00:49.042 -- 00:00:53.490 Murdad Parsi, and our Chief Financial Officer, Andrew Dickinson. 00:00:53.490 -- 00:00:57.953 After that, we'll open the call to Q&A, where the team will be joined by Cindy Peretti, 00:00:57.953 -- 00:01:02.755 the Executive Vice President of KITE. Before we get started, let me remind you that we 00:01:02.755 -- 00:01:07.138 will be making forward-looking statements, including those related to Gilead's business, 00:01:07.138 -- 00:01:11.921 financial condition and results of operations, plans and expectations with respect to 00:01:11.921 -- 00:01...